Friday, March 1, 2019

Protein content as a marker for response to therapy in brain cancer

Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists have now been able to show in a study using non-invasive high-resolution 7-Tesla MRI scans that the protein content of tumors correlates with response to treatment and survival.

from Top Health News -- ScienceDaily https://ift.tt/2BZL52A

No comments:

Post a Comment

A single protein may be holding back CAR T cancer therapy

A newly identified protein may be one of the biggest obstacles holding CAR T-cell therapy back. Researchers found that NFIL3 causes these en...